Home » Topics » Regulatory » EMA

EMA
RSS

EMA's CHMP recommends label extension for tocilizumab

May 24, 2011

EMA committee recommends accelerated approval of Victrelis for hepatitis C genotype 1

May 23, 2011

CHMP recommends approval of Vibativ for nosocomial pneumonia caused by MRSA

May 23, 2011

GSK and Human Genome Sciences receive CHMP positive opinion for Benlysta

May 23, 2011

CHMP recommends conditional marketing authorization of Fampyra

May 23, 2011

EMA acknowledges that Clinuvel's proposed dossier for afamelanotide meets all filing requirements

May 12, 2011

EMA agrees to pediatric investigational plan for rFIXFc in hemophilia B

May 9, 2011

EMA provides Keryx Biopharma with scientific advice on Zerenex in hyperphosphatemia

May 3, 2011

Clinuvel and EMA to meet regarding proposed MAA for Scenesse in EPP

April 26, 2011

Novartis withdraws MAA for Joicela in osteoarthritis

April 20, 2011

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026